Global Sterile Medical Packaging Market was valued at USD 35.16 billion in 2023 and is expected to rise USD 47.3 Bn by 2030, growing at a CAGR of 6.2% between (2025-2030)
The report "Sterile Medical Packaging Market by Application (Pharmaceutical & biological, Surgical & medical instruments, Vitro diagnostic products, Medical implants), by Type (Thermoform trays, Sterile bottles & containers, Vials & ampoules, Pre-fillable inhalers, Sterile closures, Pre-filled syringes, Blister & clamshells, Bags & pouches, Wraps), by Material (Plastics, Metals, Glass, Paper & paperboard) - Global Forecast to 2030", was valued at approximately USD 35.16 billion in 2023 and is expected to generate revenue of around USD 47.3 billion by end of 2030, growing at a CAGR of around 6.2% between 2025 and 2030.
The key drivers driving the growth of the global sterile medical packaging industry globally are growing demographics and their health needs, constant efforts by consumers, suppliers and policymakers to raise the degree of infection prevention, and the beneficial health care policies. Moreover, factors such as expanded purchasing power and increasing customer understanding of healthcare are also expected to fuel the development of the global demand for sterile medical packaging.
Packaging is an integral and inherent aspect of the food development process. It guarantees the protection of goods and the effortless transportation of products.
Different forms of sterilisation packaging, such as bags, wraps and container systems, are available on the market in various sizes and configurations for the sterilisation and packaging of medical equipment and other devices. Factors such as the implementation, consistency and availability of suitable sterilisation packaging systems are very critical for the execution of packaged content sterilisation, the preservation of packaged content sterility before the product is open for use, and the elimination of contamination-free content.
Browse 53 market data Tables and 35 Figures spread through xxx Pages and in-depth TOC on "Sterile Medical Packaging Market by Application (Pharmaceutical & biological, Surgical & medical instruments, Vitro diagnostic products, Medical implants), by Type (Thermoform trays, Sterile bottles & containers, Vials & ampoules, Pre-fillable inhalers, Sterile closures, Pre-filled syringes, Blister & clamshells, Bags & pouches, Wraps), by Material (Plastics, Metals, Glass, Paper & paperboard) - Global Forecast to 2030"
PR_TABLE
Geographical Overview:
- North America
- Europe
- Asia Pacific
- Rest of World
North America is projected to be the largest consumer of the sterile medical packaging market
Centered on the region, Asia Pacific, the Middle East & Africa, North America, Europe, and South America are segmented into the sterile medical packaging industry. North America accounted for the largest share of these, and during the forecast period it is expected to see the fastest growth. This rise can be due to the numerous regulations implemented by the FDA, which, in turn, are driving demand in this area for safe and high-quality products. Moreover, the industry has been very competitive in the area due to the involvement of several big players and strict FDA regulations.
List of the Key Companies Operating in the Sterile Medical Packaging Market are:
- Amcor Plc (Switzerland)
- Placon (U.S.)
- DuPont (U.S.)
- Steripack Ltd. (Ireland)
- Wipak Group (Finland)
- Nelipak Healthcare (U.S.)
- Tekni-Plex(U.S.)
- Sonoco (U.S.)
- BillerudKorsnäs AB (Sweden)
- ProAmpac (U.S.)
- West Pharmaceutical Services, Inc. (U.S.)
- Riverside Medical Packaging Company Ltd (UK)
- Oliver Healthcare Packaging (U.S.)
- GS Medical Packaging (Canada)
- Orchid (U.S.)
- Techinipaq Inc. (U.S.)
Latest news
Recent Market Developments:
West Pharmaceutical Services launched two line extensions in February 2020, including itsAccelTRA Select EU configurations available in Ready-to-Sterilize (RS) and Ready-to-Use (RU) steam for consumers in need of high-performance elastomer and regulatory assistance in North America, as well as its Ready-to-Sterilize (RTS)/Ready-to-Use (RTU) AccelTRA components product line with the RTS alternative available.
3M completed the purchase of Acelity, Inc. and its KCI branches around the world in October 2019. Acelity is a major global medical technology company sold under the KCI name, concentrating on specialised wound care and specialist surgical applications.
Amcor completed the Bemis purchase in June, 2019. With a comprehensive global presence, size in every area, and industry-leading R&D capabilities, this strategic convergence establishes Amcor as the global leader in consumer packaging.
Global Sterile Medical Packaging Market Coverage
Application Insight and Forecast 2025-2030
- Pharmaceutical & biological
- Surgical & medical instruments
- Vitro diagnostic products
- Medical implants
Type Insight and Forecast 2025-2030
- Thermoform trays
- Sterile bottles & containers
- Vials & ampoules
- Pre-fillable inhalers
- Sterile closures
- Pre-filled syringes
- Blister & clamshells
- Bags & pouches
- Wraps
Material Insight and Forecast 2025-2030
- Plastics
- Metals
- Glass
- Paper & paperboard
Geographical Segmentation
Sterile Medical Packaging Market by Region
North America
- By Application
- By Type
- By Material
- By Country – U.S., Canada, and Mexico
Europe
- By Application
- By Type
- By Material
- By Country – Germany, U.K., France, Italy, Spain, Russia, and Rest of Europe
Asia-Pacific (APAC)
- By Application
- By Type
- By Material
- By Country – China, Japan, India, South Korea, and Rest of Asia-Pacific
Rest of the World (RoW)
- By Application
- By Type
- By Material
- By Country – Brazil, Saudi Arabia, South Africa, U.A.E., and Other Countries